Fingerprint
Dive into the research topics of 'Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer
Pancreatobiliary Cancer Study Group of Korean Society of Gastrointestinal Cancer
Research output: Contribution to journal › Article › peer-review
21
Citations
(Scopus)